Importantly, utilizing our own dataset containing 7 NC subjects and 23 AD clinical continuum patients [14], we demonstrated that the levels of EIF1 and HSPA1B are significantly altered in the peripheral blood during AD progression. Here, EIF1 is linked to Alzheimer disease.